View All Categories
Products
  • Products
  • Supplier Name
  • ITC-HSN
Post Buying Requirement Sell Your Products
Get Quotations List Products

PanWell-DSR

ITC-HSN: 30049099

Price on Request

Min Order Qty 1

Accept Small Orders

  • Product not available

PanWell-DSR is a high-performance, dual-action gastrointestinal medication designed for the effective management of acid-peptic disorders. By combining a potent Proton Pump Inhibitor (PPI) with a reliable prokinetic agent, PanWell-DSR offers comprehensive relief from acidity, heartburn, and associated nausea.

Therapeutic Composition

  • Pantoprazole Sodium IP: 40 mg (As gastro-resistant pellets)
  • Domperidone IP: 30 mg (As prolonged release Pellets)

Uses:

  1. Gastroesophageal Reflux Disease (GERD): Rapid relief from acid reflux and heartburn.
  2. Peptic & Duodenal Ulcers: Promotes mucosal healing by maintaining optimal gastric pH
  3. Dyspepsia: Reduces bloating and fullness through improved gastric motility.
  4. NSAID-Induced Gastritis: Protects the stomach lining for patients on long-term pain medication

MEDIWELL PHARMACEUTICALS

Mumbai, India

Business Operations: Manufacturer, Merchant, Service Provider

Contact Seller

Contact us for


By clicking on ‘Send Trade Enquiry’, you agree to our terms & condition and user policies

  • PanWell-DSR is a premium combination therapy formulated to address the global rise in acid-peptic disorders. It integrates a Proton Pump Inhibitor (PPI) with a Prokinetic agent in a specialized Multi-Particulate Delivery System (MPDS) to ensure 24-hour symptom control with a single daily dose.

    PanWell-DSR utilizes a Pellet-in-Capsule system designed for maximum bioavailability:
    Pantoprazole (40mg) Enteric-Coated Pellets: Engineered to bypass the acidic environment of the stomach and release only in the alkaline environment of the small intestine.
  • Domperidone (30mg) Sustained-Release Pellets: Formulated for a controlled, prolonged release over 24 hours. This eliminates the "rollercoaster effect" of immediate-release medications, providing steady anti-emetic and prokinetic action to prevent reflux.

Main Therapeutic Uses of PanWell-DSR

  • Management of GERD (Gastroesophageal Reflux Disease)
  • Treatment of Erosive Esophagitis
  • Healing of Peptic and Duodenal Ulcers
  • Reduction of Bloating and Flatulence
  • Control of Nausea and Vomiting
  • Relief from Functional Dyspepsia


Established in: 2025
Bussiness Type: Sole Proprietorship
Bussiness Type: Manufacturer, Merchant, Service Provider
MSME: Yes
Export Turnover (3 years): US$500,000 - US$1,000,000
Countries would like to export to: Australia, Germany, Kenya, Russia, South Africa, Turkey, United Kingdom, United States, Netherlands The, Belgium, Italy, Hong Kong S.A.R., Ireland
No of employees: 1-10

Related Products

Jeridol DSR

Quick View
5.10
Send Enquiry Buy Now

Medified RABI-DSR Cap.

Quick View
1.53
Send Enquiry

Medified PANTA-DSR Cap.

Quick View
1.70
Send Enquiry